Risedronate, the BBC and me

摘要

Risedronate is a drug used to reduce fractures in women with osteoporosis. The story of the Sheffield Risedronate trial made national news when one of the clinical researchers, Aubrey Blumsohn, dissociated himself from the trial because he was refused access to the data he had helped to collect. Later, some of that data turned up. Here Martin Bland describes how he came to analyse the data on behalf of the BBC, what he found and what happened next.